Vega Investment Solutions Lowers Position in Intuitive Surgical, Inc. $ISRG

Vega Investment Solutions trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 59.2% during the second quarter, Holdings Channel.com reports. The fund owned 7,265 shares of the medical equipment provider’s stock after selling 10,530 shares during the quarter. Intuitive Surgical comprises 0.9% of Vega Investment Solutions’ portfolio, making the stock its 17th biggest holding. Vega Investment Solutions’ holdings in Intuitive Surgical were worth $3,948,000 at the end of the most recent quarter.

Several other institutional investors have also recently made changes to their positions in ISRG. Aaron Wealth Advisors LLC boosted its holdings in Intuitive Surgical by 0.8% during the second quarter. Aaron Wealth Advisors LLC now owns 2,528 shares of the medical equipment provider’s stock worth $1,374,000 after purchasing an additional 19 shares during the last quarter. Evergreen Capital Management LLC increased its stake in Intuitive Surgical by 0.5% in the 1st quarter. Evergreen Capital Management LLC now owns 4,288 shares of the medical equipment provider’s stock valued at $2,124,000 after buying an additional 20 shares during the last quarter. Rise Advisors LLC lifted its position in shares of Intuitive Surgical by 5.6% during the 1st quarter. Rise Advisors LLC now owns 378 shares of the medical equipment provider’s stock worth $187,000 after buying an additional 20 shares in the last quarter. Pinnacle Bancorp Inc. boosted its stake in shares of Intuitive Surgical by 4.1% in the 2nd quarter. Pinnacle Bancorp Inc. now owns 532 shares of the medical equipment provider’s stock worth $289,000 after buying an additional 21 shares during the last quarter. Finally, Vertex Planning Partners LLC grew its holdings in shares of Intuitive Surgical by 2.3% in the second quarter. Vertex Planning Partners LLC now owns 917 shares of the medical equipment provider’s stock valued at $498,000 after acquiring an additional 21 shares in the last quarter. Institutional investors own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages recently commented on ISRG. The Goldman Sachs Group lifted their price target on Intuitive Surgical from $567.00 to $621.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Robert W. Baird set a $655.00 target price on Intuitive Surgical in a research note on Wednesday, October 22nd. BTIG Research boosted their price target on shares of Intuitive Surgical from $529.00 to $589.00 and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Truist Financial set a $620.00 price objective on shares of Intuitive Surgical and gave the stock a “buy” rating in a report on Wednesday, October 22nd. Finally, Zacks Research raised shares of Intuitive Surgical from a “hold” rating to a “strong-buy” rating in a research report on Friday, October 24th. Two analysts have rated the stock with a Strong Buy rating, seventeen have given a Buy rating, seven have issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $607.17.

Intuitive Surgical Stock Performance

Shares of ISRG opened at $575.34 on Monday. Intuitive Surgical, Inc. has a fifty-two week low of $425.00 and a fifty-two week high of $616.00. The business has a 50-day moving average of $518.60 and a 200 day moving average of $505.04. The firm has a market cap of $206.25 billion, a P/E ratio of 76.10, a price-to-earnings-growth ratio of 5.29 and a beta of 1.68.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Tuesday, October 21st. The medical equipment provider reported $2.40 EPS for the quarter, beating the consensus estimate of $1.99 by $0.41. The business had revenue of $2.51 billion for the quarter, compared to the consensus estimate of $2.41 billion. Intuitive Surgical had a net margin of 28.58% and a return on equity of 15.08%. The company’s revenue was up 22.9% compared to the same quarter last year. During the same period in the prior year, the firm earned $1.84 earnings per share. As a group, research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current fiscal year.

Insider Activity at Intuitive Surgical

In related news, EVP Brian Edward Miller sold 3,500 shares of the firm’s stock in a transaction that occurred on Monday, November 10th. The shares were sold at an average price of $575.00, for a total value of $2,012,500.00. Following the completion of the transaction, the executive vice president directly owned 5,758 shares of the company’s stock, valued at approximately $3,310,850. This trade represents a 37.81% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Craig H. Barratt sold 750 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, November 12th. The shares were sold at an average price of $580.00, for a total transaction of $435,000.00. Additional details regarding this sale are available in the official SEC disclosure. Insiders sold a total of 108,939 shares of company stock worth $60,757,995 in the last ninety days. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.